国家医保局出手了 要管控高值耗材

2018-08-13 江南珏 赛柏蓝器械

“超级医保局”开始出手了,高值耗材将成为第一肃治对象。据陕西省人民医院官网消息,8月10日,国家医疗保障局医保组牵头人熊先军一行5人在陕西省卫计委几位官员的陪同下,到陕西省人民医院调研高值医用耗材管理工作并召开座谈会。座谈会上,熊先军说明了本次调研的目的:要从国家层面出台相关政策,提出高值医用耗材管理改革方案,控制药品、耗材费用,充分体现医生劳动价值。调研医院控费好的做法,同时了解国家政策上存在

“超级医保局”开始出手了,高值耗材将成为第一肃治对象。

据陕西省人民医院官网消息,8月10日,国家医疗保障局医保组牵头人熊先军一行5人在陕西省卫计委几位官员的陪同下,到陕西省人民医院调研高值医用耗材管理工作并召开座谈会。

座谈会上,熊先军说明了本次调研的目的:要从国家层面出台相关政策,提出高值医用耗材管理改革方案,控制药品、耗材费用,充分体现医生劳动价值。调研医院控费好的做法,同时了解国家政策上存在的问题。

意思很明确,对高值耗材的管控,国家层面将出台相关政策,牵头的将是国家医保局。

另外,“了解国家政策上存在的问题”就很实在了,世界上没有任何一个国家的政策法律具有预见性,都得从实践中找出问题和漏洞,以待后期完善。而存在的问题,很可能是一些政策落地上的问题,即理论上讲,一些政策可行,但落地困难。

而“调研医院控费好的做法”有一个看点, 2018年,中央下达陕西省公立医院综合改革效果评价考核绩效奖励资金1711万元,资金数量居全国第六位,西安市公立医院综合改革获国务院通报表彰。这其中自然有陕西省率先实行的两票制和省内10个采购联合体。

而从医院负责人的反馈看,有两点将成为接下来高值耗材领域的重点内容,一个是东西部的地域差别导致的高值耗材价格差异,另一个是医院的耗材信息化平台建设。前者是一个采购难题,后者是医院对耗材的管理难题。

医用耗材特别是高值耗材是“过度医疗”的重灾区,近年来陆续曝光的医疗腐败案件,多与此有关。

早在今年7月10日,国务院副总理韩正到国家医保局调研,重点了解了抗癌药降价、医保支付方式改革、治理高值医用耗材过度使用等工作开展情况。

2017年10月,国家发改委发布十八大以来医药价格改革专题报告,其中就明确指出,今后将重点从取消耗材加成,调查成本价,出厂、口岸及产地、周边零售价大公开,打包降价这4个方面加强高值医用耗材价格监管。

可以说,在医用耗材领域,“超级医保局”先从高值耗材开刀是一定的。

另外,不管是两票制还是联合采购,陕西省都是有示范效应的。

2017年,陕西省已分三批完成13大类高值医用耗材全国最低价限价采购,价格最高降幅98.7%,平均降幅18.37%。为了扩大效应,还提出了跨省开展医用耗材采购数据共建共享,并形成包括10个省区在内的省际医用耗材采购联盟,以数据为基础,与各省区联合议价,对挂网采购的高值医用耗材价格,每半年进行一次大调整。

这10个省区为成员的省际医用耗材采购联盟,也被称为是国内医用耗材领域成员数量最多、采购体量最大的采购联盟。

当然,调研不可能只是陕西省人民医院这一家医院,西安市的三家“国家队”医院、陕西省宝鸡市的医院也可能要去。如果到时超级医保局对高值耗材管控的相关政策要从陕西省先试点,那就更有看头了。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1771990, encodeId=cb351e7199046, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue May 28 18:53:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280418, encodeId=6ded1280418cd, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484284, encodeId=35a4148428455, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497188, encodeId=e934149e188dc, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338489, encodeId=a9ce33848920, content=谢谢分享,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Tue Aug 14 08:22:48 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338473, encodeId=efae3384e39d, content=谢谢分享,要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:37 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338472, encodeId=52463384e203, content=要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:23 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338471, encodeId=6aaa3384e1c2, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:03 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338437, encodeId=f98833843edb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 14 06:43:20 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338407, encodeId=1f5f33840e80, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 13 22:42:23 CST 2018, time=2018-08-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1771990, encodeId=cb351e7199046, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue May 28 18:53:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280418, encodeId=6ded1280418cd, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484284, encodeId=35a4148428455, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497188, encodeId=e934149e188dc, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338489, encodeId=a9ce33848920, content=谢谢分享,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Tue Aug 14 08:22:48 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338473, encodeId=efae3384e39d, content=谢谢分享,要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:37 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338472, encodeId=52463384e203, content=要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:23 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338471, encodeId=6aaa3384e1c2, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:03 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338437, encodeId=f98833843edb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 14 06:43:20 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338407, encodeId=1f5f33840e80, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 13 22:42:23 CST 2018, time=2018-08-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1771990, encodeId=cb351e7199046, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue May 28 18:53:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280418, encodeId=6ded1280418cd, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484284, encodeId=35a4148428455, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497188, encodeId=e934149e188dc, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338489, encodeId=a9ce33848920, content=谢谢分享,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Tue Aug 14 08:22:48 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338473, encodeId=efae3384e39d, content=谢谢分享,要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:37 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338472, encodeId=52463384e203, content=要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:23 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338471, encodeId=6aaa3384e1c2, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:03 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338437, encodeId=f98833843edb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 14 06:43:20 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338407, encodeId=1f5f33840e80, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 13 22:42:23 CST 2018, time=2018-08-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1771990, encodeId=cb351e7199046, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue May 28 18:53:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280418, encodeId=6ded1280418cd, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484284, encodeId=35a4148428455, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497188, encodeId=e934149e188dc, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338489, encodeId=a9ce33848920, content=谢谢分享,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Tue Aug 14 08:22:48 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338473, encodeId=efae3384e39d, content=谢谢分享,要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:37 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338472, encodeId=52463384e203, content=要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:23 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338471, encodeId=6aaa3384e1c2, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:03 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338437, encodeId=f98833843edb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 14 06:43:20 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338407, encodeId=1f5f33840e80, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 13 22:42:23 CST 2018, time=2018-08-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1771990, encodeId=cb351e7199046, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue May 28 18:53:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280418, encodeId=6ded1280418cd, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484284, encodeId=35a4148428455, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497188, encodeId=e934149e188dc, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338489, encodeId=a9ce33848920, content=谢谢分享,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Tue Aug 14 08:22:48 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338473, encodeId=efae3384e39d, content=谢谢分享,要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:37 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338472, encodeId=52463384e203, content=要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:23 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338471, encodeId=6aaa3384e1c2, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:03 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338437, encodeId=f98833843edb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 14 06:43:20 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338407, encodeId=1f5f33840e80, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 13 22:42:23 CST 2018, time=2018-08-13, status=1, ipAttribution=)]
    2018-08-14 liumin1987

    谢谢分享,学习了。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1771990, encodeId=cb351e7199046, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue May 28 18:53:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280418, encodeId=6ded1280418cd, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484284, encodeId=35a4148428455, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497188, encodeId=e934149e188dc, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338489, encodeId=a9ce33848920, content=谢谢分享,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Tue Aug 14 08:22:48 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338473, encodeId=efae3384e39d, content=谢谢分享,要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:37 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338472, encodeId=52463384e203, content=要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:23 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338471, encodeId=6aaa3384e1c2, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:03 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338437, encodeId=f98833843edb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 14 06:43:20 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338407, encodeId=1f5f33840e80, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 13 22:42:23 CST 2018, time=2018-08-13, status=1, ipAttribution=)]
    2018-08-14 chinadoctorliu_19344479

    谢谢分享,要转换思想

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1771990, encodeId=cb351e7199046, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue May 28 18:53:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280418, encodeId=6ded1280418cd, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484284, encodeId=35a4148428455, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497188, encodeId=e934149e188dc, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338489, encodeId=a9ce33848920, content=谢谢分享,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Tue Aug 14 08:22:48 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338473, encodeId=efae3384e39d, content=谢谢分享,要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:37 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338472, encodeId=52463384e203, content=要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:23 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338471, encodeId=6aaa3384e1c2, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:03 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338437, encodeId=f98833843edb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 14 06:43:20 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338407, encodeId=1f5f33840e80, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 13 22:42:23 CST 2018, time=2018-08-13, status=1, ipAttribution=)]
    2018-08-14 chinadoctorliu_19344479

    要转换思想

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1771990, encodeId=cb351e7199046, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue May 28 18:53:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280418, encodeId=6ded1280418cd, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484284, encodeId=35a4148428455, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497188, encodeId=e934149e188dc, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338489, encodeId=a9ce33848920, content=谢谢分享,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Tue Aug 14 08:22:48 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338473, encodeId=efae3384e39d, content=谢谢分享,要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:37 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338472, encodeId=52463384e203, content=要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:23 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338471, encodeId=6aaa3384e1c2, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:03 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338437, encodeId=f98833843edb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 14 06:43:20 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338407, encodeId=1f5f33840e80, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 13 22:42:23 CST 2018, time=2018-08-13, status=1, ipAttribution=)]
    2018-08-14 chinadoctorliu_19344479

    谢谢分享

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1771990, encodeId=cb351e7199046, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue May 28 18:53:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280418, encodeId=6ded1280418cd, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484284, encodeId=35a4148428455, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497188, encodeId=e934149e188dc, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338489, encodeId=a9ce33848920, content=谢谢分享,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Tue Aug 14 08:22:48 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338473, encodeId=efae3384e39d, content=谢谢分享,要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:37 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338472, encodeId=52463384e203, content=要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:23 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338471, encodeId=6aaa3384e1c2, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:03 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338437, encodeId=f98833843edb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 14 06:43:20 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338407, encodeId=1f5f33840e80, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 13 22:42:23 CST 2018, time=2018-08-13, status=1, ipAttribution=)]
    2018-08-14 1209e435m98(暂无昵称)

    学习了,谢谢分享

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1771990, encodeId=cb351e7199046, content=<a href='/topic/show?id=a70f10218197' target=_blank style='color:#2F92EE;'>#高值#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102181, encryptionId=a70f10218197, topicName=高值)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f5e38357689, createdName=guguangxiang, createdTime=Tue May 28 18:53:00 CST 2019, time=2019-05-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1280418, encodeId=6ded1280418cd, content=<a href='/topic/show?id=1bd3338451e' target=_blank style='color:#2F92EE;'>#医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33845, encryptionId=1bd3338451e, topicName=医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1484284, encodeId=35a4148428455, content=<a href='/topic/show?id=68f180433bc' target=_blank style='color:#2F92EE;'>#耗材#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80433, encryptionId=68f180433bc, topicName=耗材)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e8187964274, createdName=41514489@qq.com, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497188, encodeId=e934149e188dc, content=<a href='/topic/show?id=82b440848a4' target=_blank style='color:#2F92EE;'>#国家医保局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40848, encryptionId=82b440848a4, topicName=国家医保局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82569313637, createdName=雕雕, createdTime=Wed Aug 15 11:53:00 CST 2018, time=2018-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338489, encodeId=a9ce33848920, content=谢谢分享,学习了。, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Tue Aug 14 08:22:48 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338473, encodeId=efae3384e39d, content=谢谢分享,要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:37 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338472, encodeId=52463384e203, content=要转换思想, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:23 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338471, encodeId=6aaa3384e1c2, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2018/08/06/a313b29462d38919a70f6ff00472d6b4.jpg, createdBy=86572414239, createdName=chinadoctorliu_19344479, createdTime=Tue Aug 14 07:41:03 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338437, encodeId=f98833843edb, content=学习了,谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7c592194322, createdName=1209e435m98(暂无昵称), createdTime=Tue Aug 14 06:43:20 CST 2018, time=2018-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=338407, encodeId=1f5f33840e80, content=不错的文章值得拥有哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eff51996281, createdName=1e1b8538m79(暂无匿称), createdTime=Mon Aug 13 22:42:23 CST 2018, time=2018-08-13, status=1, ipAttribution=)]
    2018-08-13 1e1b8538m79(暂无匿称)

    不错的文章值得拥有哦

    0

相关资讯

重磅!国家药品采购试点9月启动

今天,国家医保局再次开会,讨论药品集中采购的操作细则。医保局计划9月正式启动试点城市的集中采购工作,预计10月结束本轮采购并公布相关结果。

一图读懂:国家医保局大事记

如今,距5月31日国家医疗保障局挂牌已有两个多月。这两个月以来,国家医保局动作频频,健康界梳理国家医保局挂牌后的新闻,并以长图形式展现:微信图片_20180804151133.jpg四谈抗癌药降价2018年4月和6月,国务院总理李克强两次主持召开国务院常务会议,决定对进口抗癌药实施零关税并鼓励创新药进口,加快已在境外上市新药审批、落实抗癌药降价措施、强化短缺药供应保障。国家医保局成立后,各有关部门

卫健委、医保局、药监局有哪些新动作?一文说透

今年3月21日,中共中央印发《深化党和国家机构改革方案》,一批新部门应运而生。在本轮机构改革中,有三个新组建的部门和“医药”有关,分别是国家卫健委、国家医疗保障局、国家药品监督管理局。在3月末到5月末,这三个部门先后挂牌成立。因事关“民生”,机构改革后,在一些备受公众关注的事件和涉及大众利益的改革中,时常可以看到这三个部门的“身影”、听到它们的“发声”。那么,从决定组建到现在的130多天里,

医保局:高值耗材管理方案将出

“超级医保局“开始出手了,高值耗材将成为第一肃治对象。

医保局降药价 不要掉进药品集中釆购那些“坑”

导读:自5月31日国家医疗保障局挂牌以来,关于主导开展抗癌药省级专项集中采购工作、对通过一致性评价的仿制药开展量价采购工作等新闻,频频见于报端。这是国家医疗保障局接管公立医院药品采购职能后,对采购规则的强势发力。

国家医保局再调研 这次关注的是跨省就医

2018年7月17日下午3点,国务院办公厅督查室巡视员刘忠一行来到北京大学人民医院,对跨省异地就医住院医疗费用直接结算工作进行调研。刘忠一行现场观看跨省异地就医患者办理出院结算手续,并听取了关于跨省异地就医直接结算的工作报告。国务院办公厅督查室三处处长朱信永、国家医疗保障局监管组副主任黄华波、北京市人力社保局医疗保险处副处长杨菁、北京市医疗保险事务管理中心主任杜鑫和北京市医疗保险事务管理中心书记